Table 1:
22q11DS | TH | p-value | |
---|---|---|---|
| |||
N | 79 | 70 | |
| |||
Age (years) | 22.1 (8.8) | 18.9 (3.5) | 0.0046 |
range 10.2 – 52.3 | range: 10.2 – 25.1 | ||
| |||
Sex | 42 Male (53%) | 38 Male (54%) | 0.8910 |
37 Female (46%) | 32 Female (46%) | ||
| |||
Race | 65 White (82%) | 50 White (71%) | 0.2318 |
9 AA (11%) | 15 AA (21%) | ||
5 Other (6%) | 5 Other (7%) | ||
| |||
Deletion Length | |||
A-D | 72 (91%) | ||
A-B | 3 (4%) | ||
A-C | 2 (3%) | ||
C-D | 1 (1%) | ||
FISH only | 1 (1%) | ||
| |||
Psychiatric Diagnoses | |||
Psychosis: | 9 (11%) | ||
Schizophrenia | 5 (6%) | ||
Schizoaffective Disorder | 3 (4%) | ||
Psychotic Disorder NOS | 1 (1%) | ||
Attention Deficit: | 32 (40%) | ||
Anxiety Disorder: | 43 (54%) | ||
Generalized Anxiety Disorder | 17 (22%) | ||
Other anxiety disorders | 26 (33%) | ||
Major Depressive Disorder: | 22 (28%) | ||
| |||
Psychotropic Medications | 44 (44%) | ||
SSRI | 24 (30%) | ||
Antipsychotic | 8 (10%) | ||
Stimulant | 8 (10%) | ||
Antiepileptic | 8 (10%) | ||
Unknown | 4 (6%) |